NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP

CompletedN/A

Sponsor: ResMed

Conditions: Obstructive Sleep Apnea, Central Sleep Apnea, Mixed Sleep Apnea

Interventions: PAP therapy with telemonitoring

Countries: Germany

Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.

Eligibility overview

Sex: ALL

Age: 18 Years to 99 Years

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients older than 18 years
* New indication for a prescription of a Telemonitoring (AirViewTM)-capable ResMed PAP-device
* Consent to use the telemonitoring System AirViewTM (ResMed GmbH \& Co KG)
* Signed Informed Consent

Exclusion Criteria:

\- Pregnant and breastfeeding persons

Locations (6)

Blaubeuren Abbey, Baden-Wurttemberg, Germany
Fürth, Bavaria, Germany
Nuremberg, Bavaria, Germany
Düsseldorf, North Rhine-Westphalia, Germany
Essen, North Rhine-Westphalia, Germany
Berlin, State of Berlin, Germany